Correlation Between PsyBio Therapeutics and Genelux Common

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PsyBio Therapeutics and Genelux Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PsyBio Therapeutics and Genelux Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PsyBio Therapeutics Corp and Genelux Common, you can compare the effects of market volatilities on PsyBio Therapeutics and Genelux Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PsyBio Therapeutics with a short position of Genelux Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of PsyBio Therapeutics and Genelux Common.

Diversification Opportunities for PsyBio Therapeutics and Genelux Common

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between PsyBio and Genelux is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding PsyBio Therapeutics Corp and Genelux Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genelux Common and PsyBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PsyBio Therapeutics Corp are associated (or correlated) with Genelux Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genelux Common has no effect on the direction of PsyBio Therapeutics i.e., PsyBio Therapeutics and Genelux Common go up and down completely randomly.

Pair Corralation between PsyBio Therapeutics and Genelux Common

Assuming the 90 days horizon PsyBio Therapeutics Corp is expected to generate 9.43 times more return on investment than Genelux Common. However, PsyBio Therapeutics is 9.43 times more volatile than Genelux Common. It trades about 0.06 of its potential returns per unit of risk. Genelux Common is currently generating about -0.04 per unit of risk. If you would invest  0.60  in PsyBio Therapeutics Corp on September 14, 2024 and sell it today you would lose (0.59) from holding PsyBio Therapeutics Corp or give up 98.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

PsyBio Therapeutics Corp  vs.  Genelux Common

 Performance 
       Timeline  
PsyBio Therapeutics Corp 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PsyBio Therapeutics Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental drivers, PsyBio Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
Genelux Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Genelux Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong essential indicators, Genelux Common is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

PsyBio Therapeutics and Genelux Common Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PsyBio Therapeutics and Genelux Common

The main advantage of trading using opposite PsyBio Therapeutics and Genelux Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PsyBio Therapeutics position performs unexpectedly, Genelux Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genelux Common will offset losses from the drop in Genelux Common's long position.
The idea behind PsyBio Therapeutics Corp and Genelux Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Share Portfolio
Track or share privately all of your investments from the convenience of any device
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like